• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message?

作者信息

Bernardi Simona, Malagola Michele, Polverelli Nicola, Russo Domenico

机构信息

Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, Spedali Civili of Brescia, University of Brescia, Brescia, Italy,

Unit of Blood Diseases and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, Spedali Civili of Brescia, University of Brescia, Brescia, Italy.

出版信息

Acta Haematol. 2020;143(5):509-510. doi: 10.1159/000505088. Epub 2020 Jan 9.

DOI:10.1159/000505088
PMID:31922494
Abstract
摘要

相似文献

1
Exosomes in Chronic Myeloid Leukemia: Are We Reading a New Reliable Message?慢性髓性白血病中的外泌体：我们正在解读一条新的可靠信息吗？
Acta Haematol. 2020;143(5):509-510. doi: 10.1159/000505088. Epub 2020 Jan 9.
2
Phase I/II study of low-dose azacytidine in patients with chronic myeloid leukemia who have minimal residual disease while receiving therapy with tyrosine kinase inhibitors.低剂量阿扎胞苷用于慢性髓性白血病患者的I/II期研究，这些患者在接受酪氨酸激酶抑制剂治疗时存在微小残留病。
Leuk Lymphoma. 2017 Mar;58(3):722-725. doi: 10.1080/10428194.2016.1207767. Epub 2016 Sep 23.
3
BCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoring.BCR-ABL PCR 检测在慢性髓性白血病中的应用：靶向癌症治疗和监测的分子诊断。
Expert Rev Mol Diagn. 2013 Sep;13(7):749-62. doi: 10.1586/14737159.2013.835573.
4
Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.BCR-ABL的敏感复制实时定量PCR显示长期异基因干细胞移植慢性髓性白血病患者有深度分子反应。
Biol Blood Marrow Transplant. 2015 Oct;21(10):1852-5. doi: 10.1016/j.bbmt.2015.06.018. Epub 2015 Jul 4.
5
A new highly sensitive real-time quantitative-PCR method for detection of BCR-ABL1 to monitor minimal residual disease in chronic myeloid leukemia after discontinuation of imatinib.一种新的高灵敏度实时定量 PCR 方法，用于检测 BCR-ABL1，以监测伊马替尼停药后慢性髓性白血病的微小残留病。
PLoS One. 2019 Mar 5;14(3):e0207170. doi: 10.1371/journal.pone.0207170. eCollection 2019.
6
Novel tyrosine kinase inhibitors in chronic myelogenous leukemia.慢性粒细胞白血病中的新型酪氨酸激酶抑制剂
Curr Opin Oncol. 2006 Nov;18(6):578-83. doi: 10.1097/01.cco.0000245314.97638.d3.
7
[Importance of quantitative evaluation of BCR-ABL transcripts using real-time PCR for effective treatment of chronic myeloid leukemia].[采用实时荧光定量聚合酶链反应对BCR-ABL转录本进行定量评估在慢性髓性白血病有效治疗中的重要性]
Cas Lek Cesk. 2006;145(1):25-9; discussion 29-30.
8
Reconsideration of BCR-ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?重新审视BCR-ABL蛋白流式细胞术免疫微珠检测：对慢性髓性白血病的诊断和监测效力如何？
Int J Lab Hematol. 2015 Oct;37(5):723-8. doi: 10.1111/ijlh.12394. Epub 2015 Jun 9.
9
Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction--is it truly a benign disease?伴有e19a2（c3a2）BCR/ABL融合连接的慢性髓性白血病——它真的是一种良性疾病吗？
Leukemia. 1998 Jul;12(7):1166-7. doi: 10.1038/sj.leu.2401055.
10
Comparative In vitro cellular data alone are insufficient to predict clinical responses and guide the choice of BCR-ABL inhibitor for treating imatinib-resistant chronic myeloid leukemia.仅比较体外细胞数据不足以预测临床反应并指导用于治疗伊马替尼耐药慢性髓性白血病的BCR-ABL抑制剂的选择。
J Clin Oncol. 2010 Apr 10;28(11):e169-71; author reply e172. doi: 10.1200/JCO.2009.26.4945. Epub 2010 Mar 1.

引用本文的文献

1
The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers.慢性髓系白血病的生物学：新见解与生物标志物概述
Front Oncol. 2025 May 8;15:1546813. doi: 10.3389/fonc.2025.1546813. eCollection 2025.
2
Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules.慢性髓性白血病中的细胞外囊泡：疾病标志物与治疗分子转运的最新进展
Front Oncol. 2024 Jan 8;13:1239042. doi: 10.3389/fonc.2023.1239042. eCollection 2023.
3
Liquid biopsies and minimal residual disease in lymphoid malignancies.
液体活检与淋巴系统恶性肿瘤中的微小残留病
Front Oncol. 2023 May 9;13:1173701. doi: 10.3389/fonc.2023.1173701. eCollection 2023.
4
Feasibility of Leukemia-Derived Exosome Enrichment and Co-isolated dsDNA Sequencing in Acute Myeloid Leukemia Patients: A Proof of Concept for New Leukemia Biomarkers Detection.急性髓系白血病患者白血病衍生外泌体富集及共分离双链DNA测序的可行性：新型白血病生物标志物检测的概念验证
Cancers (Basel). 2022 Sep 16;14(18):4504. doi: 10.3390/cancers14184504.
5
Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These "".髓系肿瘤中的外泌体与细胞外囊泡：这些“”所发挥的多重复杂作用
Biology (Basel). 2021 Feb 2;10(2):105. doi: 10.3390/biology10020105.
6
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?慢性粒细胞白血病新旧方法中的分子检测：我们正处在转折点吗？
J Clin Med. 2020 Nov 27;9(12):3865. doi: 10.3390/jcm9123865.
7
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients?逆转录定量聚合酶链反应（RT-qPCR）与数字聚合酶链反应（Digital PCR）：它们对慢性髓性白血病患者的临床管理有何不同影响？
Case Rep Oncol. 2020 Oct 15;13(3):1263-1269. doi: 10.1159/000510440. eCollection 2020 Sep-Dec.
8
Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients.从转移性黑色素瘤患者的血浆中分离细胞外囊泡可提高突变 DNA 的检测率。
Sci Rep. 2020 Sep 25;10(1):15745. doi: 10.1038/s41598-020-72834-6.
9
Extracellular Vesicles: From Biomarkers to Therapeutic Tools.细胞外囊泡：从生物标志物到治疗工具
Biology (Basel). 2020 Aug 31;9(9):258. doi: 10.3390/biology9090258.